Drugs / Canvert-M
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07093138 | Jul → Sep 2025 overdue | migraine disorder | Alasht Pharmed | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Canvert-M | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07093138 ↗ |
| Route | Topical | “topical roll-on formulation” NCT07093138 ↗ |